Skip to content

Gastrointestinal Disorders

Main result

6.62points

Quality-of-life improvement (IBS-QOL)

PLOS ONE · Zhou et al. · 2025 · 2,038 participants

The effect of acupuncture on quality of life in patients with irritable bowel syndrome: A systematic review and meta-analysis

Moderate
  • −46.58 points

    Reduction in symptom severity (IBS-SSS)

  • Not significant (p=0.21)

    Reduction in abdominal pain

Study design sheet

  • n=2,038 participants
  • High Clinical Impact
Design
Systematic Review and Meta-analysis
Participants
2,038

n = 2,038; median of studies with the same design: 1,449

Duration

4 to 13 weeks

Treatments of 4 to 13 weeks

OBJECTIVE
To assess the effect of acupuncture on quality of life in patients with irritable bowel syndrome
WHO
2,038 patients with IBS diagnosed by Rome I-IV criteria
POINTS
Several protocols including manual acupuncture, electroacupuncture, and transcutaneous stimulation
Results in numbers
  • 6.62 pointsQuality-of-life improvement (IBS-QOL)
  • −46.58 pointsReduction in symptom severity (IBS-SSS)
  • Not significant (p=0.21)Reduction in abdominal pain
  • Reported in 3 of 14 studies; mild and transientAdverse events

What does this mean for you?

This analysis of 14 studies with more than 2,000 patients indicates that acupuncture may improve quality of life and reduce symptom severity in irritable bowel syndrome, with no significant effect on abdominal pain. Only three studies reported adverse events, all mild and transient. The authors conclude that acupuncture may be a feasible and safe intervention and call for higher-quality studies.

Article summary

Plain-language narrative summary

This meta-analysis assessed the effects of acupuncture on quality of life in patients with irritable bowel syndrome (IBS), analyzing data from 14 randomized controlled trials involving 2,038 participants across multiple countries, including China, the United Kingdom, Germany, the United States, Turkey, and Canada. IBS is a functional bowel disorder affecting 3-15% of the world's population, characterized by recurrent abdominal pain and altered bowel habits, with substantial impact on quality of life and considerable economic costs. The investigators conducted a systematic search of four major databases (PubMed, Cochrane, Embase, and Web of Science) through September 2023, including only randomized controlled trials published in English that compared acupuncture (manual, electroacupuncture, or transcutaneous stimulation) with appropriate controls (sham acupuncture, medications, or usual care). The primary outcome was quality of life measured by validated scales, primarily IBS-QOL, while secondary outcomes included the symptom severity scale (IBS-SSS) and abdominal pain.

The analysis showed that acupuncture provided significant improvement in quality of life compared with conventional treatment (mean difference = 6.62 points; 95% CI: 2.30 to 10.94; p<0.001), with substantial statistical heterogeneity across studies (I²=72.45%). Additionally, acupuncture demonstrated superiority in reducing IBS symptom severity (mean difference = -46.58 points; 95% CI: -91.49 to -1.68; p<0.001; I²=90.76%), indicating a benefit on symptom severity, also with substantial heterogeneity. Subgroup analyses provided valuable insights into optimal treatment parameters, with the hypothesis that 30-minute sessions, performed up to five times per week for four weeks, may be the optimal parameters for improving quality of life. In the subgroups, sessions shorter than 30 minutes showed a significant effect and those longer than 30 minutes did not.

Interestingly, acupuncture proved superior to conventional medications for improving quality of life, offering an important therapeutic alternative considering that many IBS medications produce adverse effects such as nausea and constipation. Detailed analysis of the eight IBS-QOL dimensions revealed that acupuncture was particularly effective in improving somatic complaints, health concerns, interpersonal relationships, sexual problems, and interference with daily activities, demonstrating holistic benefits beyond symptomatic relief. Regarding safety, only three studies reported adverse events, all transient and mild, including subcutaneous hematoma, abdominal pain, cold extremities, and neural pain, with no serious adverse effects. However, acupuncture did not demonstrate significant efficacy for reducing abdominal pain compared with controls, a result that differs from some prior meta-analyses and may relate to differences in treatment protocols or inadequate sample size for this specific outcome.

Limitations of the study include a predominant focus on short-term efficacy, relatively small sample sizes in most individual studies, geographic concentration of studies (mainly China), reliance on subjective outcome measures, and lack of long-term follow-up data. Despite these limitations, overall methodological quality was considered good, with low risk of bias in most assessed domains. Proposed mechanisms for the benefits of acupuncture include modulation of intestinal inflammation through inhibition of TRPV1 channels in peripheral sensory neurons, regulation of serotonin receptors (reduction of 5-HT3R and increase of 5-HT4R), improved gastrointestinal motility, and central effects on the hypothalamic-pituitary-adrenal axis, resulting in reduced visceral hypersensitivity characteristic of IBS. These findings have important clinical implications, especially considering the increased incidence of IBS during the COVID-19 pandemic and the growing demand for integrative therapies.

The authors conclude that acupuncture may be a feasible and safe intervention for improving quality of life in IBS, and note that studies with larger samples, long-term follow-up, and higher methodological quality are needed.

Strengths

  • Large sample of 2,038 participants from multiple countries
  • Comprehensive analysis of optimal treatment parameters
  • Low risk of bias in most studies
  • Detailed analysis of specific quality-of-life dimensions
  • Evidence of superiority over conventional medications

Limitations

  • Predominant focus on short-term efficacy
  • Geographic concentration of studies, mainly in China
  • Reliance on subjective outcome measures
  • Lack of long-term follow-up data

Historical Context

The 4 events to scale, from 2005 to 2025: the distance between dots is proportional to time. In blue, this study. The longest gap runs from 2005 to 2020 (15 years).
  1. 2005Ano de publicação do ensaio mais antigo incluído nesta meta-análise
  2. 2020Aumento da incidência de SII durante COVID-19
  3. 2023Busca sistemática até setembro para esta meta-análise
  4. 2025Publicação desta meta-análise abrangente
Prof. Dr. Hong Jin Pai

Expert Commentary

Clinical Relevance

Irritable bowel syndrome occupies a disproportionate share of any gastroenterology or pain clinic, and dissatisfaction with available pharmacological options is a common denominator among these patients. This meta-analysis, by pooling data from 2,038 participants across multiple countries, consolidates acupuncture as an integrative strategy with measurable impact on quality of life — 6.62 points on IBS-QOL and a 46.58-point reduction in symptom severity by IBS-SSS. The most clinically relevant finding is the superiority over conventional medications in the quality-of-life dimension, especially considering that antispasmodics, antidiarrheals, and motility regulators carry adverse-event profiles that compromise adherence. The paper also points to specific dimensions that benefit — somatic complaints, health concerns, interpersonal relationships, and interference with daily activities — which allows the clinician to communicate realistic expectations to the patient before starting treatment.

Notable Findings

The most striking finding is not the global effect, expected by anyone who follows the literature, but the breakdown of the eight IBS-QOL dimensions: acupuncture proved effective in domains rarely targeted directly by any pharmacological intervention, such as sexual dysfunction and impact on interpersonal relationships. This indicates that the benefit is not simply cramp reduction, but functional reintegration of the patient into daily life. Equally notable is the finding that isolated abdominal pain did not reach statistical significance — reinforcing that IBS should be treated as a multidimensional syndrome, not as the equivalent of visceral pain. Proposed mechanisms are biologically plausible: modulation of TRPV1 channels, regulation of serotonergic receptors (reduction of 5-HT3R and increase of 5-HT4R), and effects on the hypothalamic-pituitary-adrenal axis. Safety was consistent, with adverse events reported in only three studies, all mild and transient.

From My Experience

In my practice, IBS has always been one of the indications in which acupuncture most consistently delivers what the patient values most: returning to social life without permanent defensive planning around bowel symptoms. I have observed perceptible response from the third or fourth session, especially with reduction of urgency and anticipatory anxiety, which is a frequently underestimated component. I usually work with an initial cycle of eight to ten sessions, twice a week, combining acupuncture with nutritional guidance and, when there is a significant anxiety component, with a cognitive-behavioral approach. At the Pain Center, the patients who respond best are those with predominantly diarrheal or mixed subtype, with high psychosocial burden, and who have already tried at least two pharmacologic regimens without satisfaction. The protocol indicated by the article — 30-minute sessions with a frequency of up to five times weekly for four weeks — is more intensive than usual at our service, but the subgroup data justify considering this density in more refractory cases.

Prof. Dr. Hong Jin Pai · PhD in Sciences, University of São Paulo

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0314678

Access original article

Scientific review

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.

  • Strong
  • Moderate
  • Limited
  • Weak
19801990200020102020
This study among the Library’s studiesEach dot is a study: left to right, the publication year; top to bottom, the study design, from meta-analyses to preclinical work; colour and shape give the level of evidence. Highlighted: the Gastrointestinal Disorders studies.
See the numbers: This study among the Library’s studies
Study designGastrointestinal DisordersAll studies
Meta-analysis · Systematic Review25387
RCT18224
Clinical Guideline05
Observational038
Case Series17
Narrative Review5155
Preclinical / Animal06
Other6203
See the Gastrointestinal Disorders studies in the Library

Related articles

Based on this article’s categories

  1. Liao et al. · Complementary Therapies in Medicine · 2024

    • Systematic Reviews & Meta-Analyses
    • Gastrointestinal Disorders
  2. Li et al. · Frontiers in Medicine · 2026

    • Gastrointestinal Disorders
    • Systematic Reviews & Meta-Analyses
  3. Li et al. · Postgraduate Medical Journal · 2026

    • Gastrointestinal Disorders
    • Systematic Reviews & Meta-Analyses
  4. Mao et al. · Medicine · 2020

    • Electroacupuncture
    • Gastrointestinal Disorders
    • Systematic Reviews & Meta-Analyses